The use of DeltaScan for delirium screening reduces length of hospital stay and increase the detection of delirium, in comparison with the Delirium Observation Scale
ID
Bron
Verkorte titel
Aandoening
Heart diseases
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Two primary endpints: Length of hospital stay after cardiac surgery, and incidence of detected delirium at the surgical ward
Achtergrond van het onderzoek
Delirium is a serious and common neuropsychiatric disorder (American Psychiatric Association, 2013) that is related to adverse long-term outcomes (Inouye, Westendorp, & Saczynski, 2014a). Postoperative delirium occurs often in hospitalized older patients following cardiac surgery, with an incidence in the postoperative period of 17% (including elective patients aged ≥45 years, (Koster, Hensens, Schuurmans, & Van Der Palen, 2012) and 13% (including elective adult patients,(ten Broeke, Koster, Konings, Hensens, & van der Palen, 2018)) respectively. Early detection of delirium enables early treatment of the underlying cause. Therefore, screening for delirium in patients at risk is an important part of clinical follow-up after surgery (Inouye, Westendorp, & Saczynski, 2014b; Marcantonio, 2017a; Nederlandse Vereniging voor Klinische Geriatrie, 2013; Samuel et al., 2015)
Although delirium screening is part of routine practice following cardiac surgery, patients with a hypoactive or mixed form of delirium are possibly missed (Marcantonio, 2017b). Current screening methods, such as the DOSS, are subjective. Although the DOSS is a sensitive instrument in research settings, during care-as-usual the sensitivity may decrease to 32% (Numan et al., 2017).
Recently, an objective medical device has been developed that can detect delirium based on a short one-channel EEG measurement: DeltaScan (Numan et al., 2019). Using DeltaScan in routine care may improve the delirium detection (Numan et al., 2019). Furthermore, improved detection of delirium may lead to improved patient outcomes such as length of stay and therefore to reduced hospital costs (Gleason et al., 2015; Lundstrom et al, 2005; Young & George, 2003).
In the present study, we aim to assess whether introduction of DeltaScan in routine clinical care as screening instrument for delirium, will (1) increase the reported incidence of delirium in the postoperative period, and (2) reduce hospital stay of delirious patients in the postoperative period at Thoraxcentrum Twente (TCT).
Doel van het onderzoek
The use of DeltaScan for delirium screening reduces length of hospital stay and increase the detection of delirium, in comparison with the Delirium Observation Scale
Onderzoeksopzet
Surgical ward; 30-days after surgery
Onderzoeksproduct en/of interventie
Patients are screend for delirium with DeltaScan or the Delirium Observation Scale. The treatment of delirium is identical, and is according to hospital protocols.
Publiek
Wetenschappelijk
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
Patients over 70 years of age who received cardiac surgery (including TAVI patients with a thoracotomy) in the MST Thoraxcentrum Twente
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
Patients who use lithium, have metal cranial implants, have dementia or other diseases that influence EEG measurements (i.e. acute brain damage) are excluded, because these are contraindications for DeltaScan use. Patients who opted-out of this study will be excluded as well.
Opzet
Deelname
Voornemen beschikbaar stellen Individuele Patiënten Data (IPD)
Toelichting
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL9435 |
Ander register | METC Twente : K20-58 |